Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Erritzoe

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Psychopharmacology|August 11, 2017
Psychedelics and connectednessR L Carhart-Harris, D Erritzoe, E Haijen, et al.
Neuroscience|June 30, 2009
Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor bindingV G Frokjaer, D Erritzoe, J Madsen, et al.
Synapse (New York, N.Y.)|August 29, 2012
Influence of different cellular environments on [(3)H]DASB radioligand bindingD R Quelch, C A Parker, D J Nutt, et al.
International Review of Neurobiology|June 20, 2025
Serotonergic psychedelics for depression: A comprehensive overviewA M Wingert, C Agnorelli, J Peill, et al.
Current Topics in Behavioral Neurosciences|November 13, 2023
Psilocybin and Other Classic Psychedelics in DepressionD J Nutt, J M Peill, B Weiss, et al.
Acta Psychiatrica Scandinavica|June 21, 2018
Effects of psilocybin therapy on personality structureD Erritzoe, L Roseman, M M Nour, et al.
Scientific Reports|January 22, 2021
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosingL S Kaertner, M B Steinborn, H Kettner, et al.
Neuroimage|April 13, 2010
Cerebral serotonin transporter binding is inversely related to body mass indexD Erritzoe, V G Frokjaer, M T Haahr, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 28, 2012
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybinR L Carhart-Harris, R Leech, T M Williams, et al.
Neuroimage|May 22, 2009
Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol useD Erritzoe, V G Frokjaer, S Haugbol, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Psychopharmacology|August 11, 2017
Psychedelics and connectednessR L Carhart-Harris, D Erritzoe, E Haijen, et al.
Neuroscience|June 30, 2009
Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor bindingV G Frokjaer, D Erritzoe, J Madsen, et al.
Synapse (New York, N.Y.)|August 29, 2012
Influence of different cellular environments on [(3)H]DASB radioligand bindingD R Quelch, C A Parker, D J Nutt, et al.
International Review of Neurobiology|June 20, 2025
Serotonergic psychedelics for depression: A comprehensive overviewA M Wingert, C Agnorelli, J Peill, et al.
Current Topics in Behavioral Neurosciences|November 13, 2023
Psilocybin and Other Classic Psychedelics in DepressionD J Nutt, J M Peill, B Weiss, et al.
Acta Psychiatrica Scandinavica|June 21, 2018
Effects of psilocybin therapy on personality structureD Erritzoe, L Roseman, M M Nour, et al.
Scientific Reports|January 22, 2021
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosingL S Kaertner, M B Steinborn, H Kettner, et al.
Neuroimage|April 13, 2010
Cerebral serotonin transporter binding is inversely related to body mass indexD Erritzoe, V G Frokjaer, M T Haahr, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 28, 2012
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybinR L Carhart-Harris, R Leech, T M Williams, et al.
Neuroimage|May 22, 2009
Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol useD Erritzoe, V G Frokjaer, S Haugbol, et al.
Pageof 2